Apatech Case Study
Apatech leads the market in the supply of synthetic bone graft materials for orthopaedic applications.
Apatech’s range of silicon-substituted hydroxyapatite materials have revolutionized the bone graft market, stimulating natural bone growth for applications in spinal surgery, trauma and dentistry. Apatech’s Actifuse product family has become the surgeon’s choice in a large number of hospitals across the US and Europe.
Apatech started life as a spin-out from Queen Mary, University of London in 2001, and grew to become a London-based company with commercial operations in the US and Germany, and revenues in excess of $60m in 2010. This saw the company be recognised as the 2nd fastest growing UK company in the Sunday Times 2009 Tech Track and the fastest growing medical business for the third year running. Apatech was also rated the fastest growing healthcare company in the Deloitte Technology Fast 50.
Apatech’s growth led to a takeover by Baxter International in 2010 for an acquisition sum of $330m.
2010 | Baxter International Inc. acquires Apatech for $330m in March 2010
2009 | DFJ Esprit acquires Apatech as part of 3i's European venture portfolio in September 2009
2007 | Apatech sees revenues grow from $7m to $63m from 2007 to 2010 [and employees from 40 to 140 in the same period]